SCHEMBL16997277

SCHEMBL16997277

Cc1ccc(-c2nc(-c3ccc(C)cc3)nc(-c3ccc(C)c(-c4cccc5c4c4cc(-c6ccccc6)ccc4n5-c4ccccc4)c3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.35
ALDH1A1 P00352 2/20 0.35
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
AVPR1A P37288 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NPC1 O15118 2/20 0.34
LMNA P02545 2/20 0.34
RAB9A P51151 2/20 0.34
AKR1C4 P17516 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
AKR1C1 Q04828 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PDE10A Q9Y233 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16997276 0.97 AVPR1A (0.36) RXFP1AVPR1AMEN1KMT2ANPC1
SCHEMBL16997275 0.95 RXRA (0.34) RXFP1AVPR1AMEN1KMT2ANPC1
SCHEMBL16997274 0.94 PDE10A (0.33) RXFP1AVPR1AMEN1KMT2ANPC1
SCHEMBL16997287 0.91 ALDH1A1 (0.37) RXFP1ALDH1A1SIRT2SIRT1MEN1
SCHEMBL16997278 0.91 AKR1C4 (0.36) RXFP1ALDH1A1MEN1KMT2ALMNA
SCHEMBL16997286 0.91 ALDH1A1 (0.37) RXFP1ALDH1A1SIRT2SIRT1MEN1
SCHEMBL16997308 0.91 RXFP1 (0.37) RXFP1ALDH1A1SIRT2SIRT1AVPR1A
SCHEMBL16997270 0.90 RXFP1 (0.35) RXFP1ALDH1A1SIRT2SIRT1MEN1
SCHEMBL16997279 0.90 ALDH1A1 (0.34) RXFP1ALDH1A1SIRT2SIRT1MEN1
SCHEMBL16997282 0.89 KDM4E (0.36) RXFP1MEN1KMT2ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9911925-B2 Carbazole-based compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-03-06 US disclosed
US-9911925-B2 Carbazole-based compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-03-06 US disclosed
US-20150228908-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-08-13 US disclosed
US-20150228908-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150228908-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1B1, CYP1A1, CRY1 RXFP1 1583/4885ALDH1A1 45/4885SIRT2 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.